Eli Lilly

US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters
Tue, 09/26/23 - 09:49 pm
Eli Lilly
Teva Pharmaceutical
migraines
Ajovy
Emgality
patents
legal
Eli Lilly receives UK approval for ulcerative colitis treatment
Biopharma Reporter
Mon, 09/25/23 - 10:13 am
Eli Lilly
NICE
UK
ulcerative colitis
mirikizumab
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Fri, 09/22/23 - 11:50 am
Eli Lilly
Boehringer Ingelheim
Medicare
Jardiance
FDA
chronic kidney disease
Cell therapy developer closes funding round to support diabetes program
BioPharma Dive
Thu, 09/21/23 - 11:48 am
cell therapy
Seraxis
funding
Eli Lilly
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
CNBC
Tue, 09/19/23 - 10:26 pm
Eli Lilly
legal
Mounjaro
diabetes
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Fierce Pharma
Mon, 09/11/23 - 12:26 pm
Novo Nordisk
Eli Lilly
GLP-1 agonist
obesity
The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab
BioSpace
Mon, 09/11/23 - 12:34 pm
Alzheimer's disease
Eli Lilly
Biogen
Eisai
Leqembi
donanemab
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
NICE changes its mind on Lilly's Mounjaro for diabetes
Pharmaphorum
Fri, 09/8/23 - 10:09 am
Eli Lilly
Mounjaro
diabetes
NHS
UK
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Competing in These 3 Markets Could Send Eli Lilly Stock Soaring
Motley Fool
Tue, 09/5/23 - 11:23 am
Eli Lilly
Alzheimer's disease
obesity
painkillers
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Clinical Trials Arena
Thu, 08/31/23 - 06:02 pm
Eli Lilly
retatrutide
clinical trials
NASH
obesity
diabetes
type 2 diabetes
US senators push drugmakers for details on low-cost insulin programs
Yahoo/Reuters
Thu, 08/31/23 - 10:11 am
Senate
insulin
drug pricing
Novo Nordisk
Eli Lilly
Sanofi
diabetes
With $25K donation to Pence PAC, Lilly CEO Ricks defies some of company's stated positions
Fierce Pharma
Wed, 08/30/23 - 11:22 pm
Eli Lilly
Pharma CEOs
Dave Ricks
Mike Pence
2024 Presidential election
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
Lilly’s Cholesterol Pill Shows Early Promise in Phase I Study
BioSpace
Tue, 08/29/23 - 11:15 am
Eli Lilly
muvalaplin
clinical trials
cholesterol
More US States Take on Eli Lilly in Court Over Proposed $13.5 Million Insulin Pricing Settlement
Xtalks
Sun, 08/27/23 - 04:38 pm
Eli Lilly
legal
insulin
Humalog
drug pricing
Arizona
Mississippi
Minnesota
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Wed, 08/23/23 - 10:12 am
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
earnings
Eli Lilly
JNJ
Novo Nordisk
Novartis
AstraZeneca
Lilly's $13.5M insulin pricing settlement gets pushback from 9 states
Fierce Pharma
Thu, 08/17/23 - 10:16 am
Eli Lilly
drug pricing
insulin
Humalog
legal
diabetes

Pages